936801-41-1 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
5-(Ethoxycarbonyl)-2-Methylnicotinic acid is used as a research compound for the development of new pharmaceuticals. Its unique structure and properties make it a valuable tool in the discovery and optimization of potential therapeutic agents.
Used in the Treatment of Inflammation and Autoimmune Diseases:
In the medical field, 5-(Ethoxycarbonyl)-2-Methylnicotinic acid is used as a therapeutic agent for the treatment of inflammation and autoimmune diseases. Its potential to modulate immune responses and reduce inflammation makes it a promising candidate for the management of such conditions.
Used as an Antitumor Agent:
5-(Ethoxycarbonyl)-2-Methylnicotinic acid is being studied for its potential to act as an antitumor agent. Its ability to target and inhibit the growth of cancer cells has generated interest in its use as a component of cancer treatment strategies.
Used in the Synthesis of Pharmaceutical Intermediates and Active Pharmaceutical Ingredients:
In the chemical synthesis industry, 5-(Ethoxycarbonyl)-2-Methylnicotinic acid is used as a key intermediate in the production of various pharmaceutical intermediates and active pharmaceutical ingredients. Its versatility in chemical reactions allows for the creation of a wide range of medicinal compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 936801-41-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,8,0 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 936801-41:
(8*9)+(7*3)+(6*6)+(5*8)+(4*0)+(3*1)+(2*4)+(1*1)=181
181 % 10 = 1
So 936801-41-1 is a valid CAS Registry Number.
936801-41-1Relevant academic research and scientific papers
BISAMIDE CYTOKINE INHIBITORS
-
Page/Page column 107, (2008/06/13)
The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are bisamides and are useful as anti-inflammatory agents. In one aspect the compounds have the
